TNFRSF9 and cancer: Further analyses showed that these high HLA‐DR+ cancer cell tumors exhibited elevated levels of LAG3, TNFRSF9, CTLA4, PDCD1, TIGIT, ITGB2, and GZMB (Figure 4C).